Natural killer T cells in pulmonary disorders

Respiratory Medicine

Volumn 105, Issue SUPPL. 1, 2011, Pages

  Rijavec, Matija ^a   Volarevic, Sinisa ^b   Osolnik, Katarina ^a   Kosnik, Mitja ^a   Korosec, Peter ^a  

^a UNIVERSITY CLINIC OF RESPIRATORY AND ALLERGIC DISEASES   (Slovenia)

^b UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

Asthma; COPD; Hypersensitivity; Lung cancer; NKT cells; Pneumonitis; Sarcoidosis; Tuberculosis

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD161 ANTIGEN; CD1D ANTIBODY; CD1D ANTIGEN; CD56 ANTIGEN; CELL ANTIBODY; DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ALLERGIC ASTHMA; ALLERGIC PNEUMONITIS; ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; ARTICLE; ASTHMA; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL TRANSPLANTATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; IMMUNOREGULATION; IMMUNOTHERAPY; INNATE IMMUNITY; LUNG DISEASE; LUNG LAVAGE; LUNG NON SMALL CELL CANCER; LUNG SARCOIDOSIS; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; NATURAL KILLER T CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; TREATMENT RESPONSE; TUBERCULOSIS;

ADAPTIVE IMMUNITY; ASTHMA; FEMALE; HUMANS; IMMUNOTHERAPY; LUNG DISEASES, INTERSTITIAL; LYMPHOCYTE ACTIVATION; MALE; NATURAL KILLER T-CELLS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; T-LYMPHOCYTE SUBSETS; TUBERCULOSIS;

EID: 80054967252     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/S0954-6111(11)70006-3     Document Type: Article

References (63)

1. SP Berzins, MJ Smyth, AG Baxter Presumed guilty: natural killer T cell defects and human disease Nat Rev Immunol 11 2011 131 142
2. Dl Godfrey, S Stankovic, AG Baxter Raising the NKT cell family Nat Immunol 11 2010 197 206
3. Dl Godfrey, HR MacDonald, M Kronenberg, MJ Smyth, L Van Kaer NKT cells: what's in a name? Nat Rev Immunol 4 2004 231 237 (Pubitemid 38339089)
4. L Van Kaer, VP Vrajesh, W Lan Invariant natural killer T cells: bridging innate and adaptive immunity Cell Tissue Res 343 2011 43 55
5. M Kronenberg, L Gapin The unconventional lifestyle of NKT cells Nat Rev Immunol 2 2002 557 568 (Pubitemid 37328731)
6. M Satoh, S Seki, W Hashimoto, K Ogasawara, T Kobayashi, K Kumagai et al. Cytotoxic gammadelta of alphabeta T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2 J Immunol 157 1996 3886 3892 (Pubitemid 126449296)
7. JL Matsuda, OV Naidenko, L Gapin, T Nakayama, M Taniguchi, CR Wang et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers J Exp Med 192 2000 741 754
8. A Bendelac, PB Savage, L Teyton The biology of NKT cells Annu Rev Immunol 25 2007 297 336 (Pubitemid 46697911)
9. D Zhou, J Mattner, C Cantu 3rd, N Schrantz, N Yin, Y Gao et al. Lysosomal glycosphingolipid recognition by NKT cells Science 306 2004 1786 1789 (Pubitemid 39601398)
10. HJ Wajchman, CW Pierce, VA Varma, MM Issa, J Petros, KE Dombrowski Ex vivo expansion of CD8+CD56+ and CD8+CD56-natural killer T cells specific for MUC1 mucin Cancer Res 64 2004 1171 1180
11. JE Gumperz, S Miyake, T Yamamura, MB Brenner Functionally distinct subsets of CD1 d-restricted natural killer T cells revealed by CD1d tetramer staining J Exp Med 195 2002 625 636 (Pubitemid 34461507)
12. JM Coquet, S Chakravarti, K Kyparissoudis, FW McNab, LA Pitt, BS McKenzie et al. Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1-NKT cell population Proc Natl Acad Sci USA 105 2008 11287 11292
13. ML Michel, AC Keller, C Paget, M Fujio, F Trottein, PB Savage et al. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia J Exp Med 204 2007 995 1001 (Pubitemid 46798144)
14. AV Rachitskaya, AM Hansen, R Horai, Z Li, R Villasmil, D Luger et al. Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion J Immunol 180 2008 5167 5171
15. A Jahng, I Maricic, C Aguilera, S Cardell, RC Haider, V Kumar Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactiveTcell population reactive to sulfatide J Exp Med 199 2004 947 957 (Pubitemid 38481086)
16. I Van Rhijn, DC Young, JS Im, SB Levery, PA lllarionov, GS Besra et al. CD1d-restricted T cell activation by nonlipidic small molecules Proc Natl Acad Sci USA 101 2004 13578 13583 (Pubitemid 39238445)
17. KJ Hammond, SB Pelikan, NY Crowe, E Randle-Barrett, T Nakayama, M Taniguchi et al. NKT cells are phenotypically and functionally diverse Eur J Immunol 29 1999 3768 3781 (Pubitemid 29527827)
18. MJ Smyth, Dl Godfrey NKT cells and tumor immunity-a double-edged sword Nat Immunol 1 2000 459 460
19. SB Wilson, TL Delovitch Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity Nat Rev Immunol 3 2003 211 222 (Pubitemid 37323206)
20. G Galli, S Nuti, S Tavarini, L Galli-Stampino, C De Lalla, G Casorati et al. Innate immune responses support adaptive immunity: NKT cells induce B cell activation Vaccine 21 2003 S48 S54 (Pubitemid 36603316)
21. K Seino, M Taniguchi Functionally distinct NKT cell subsets and subtypes J Exp Med 202 2005 1623 1626 (Pubitemid 41815867)
22. O Akbari, JL Faul, EG Hoyte, GJ Berry, J Wahlstrom, M Kronenberg et al. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma N Engl J Med 354 2006 1117 1129
23. N Pham-Thi, J deBlic, M LeBourgeois, M Dy, P Scheinmann, MC Leite-de-Moraes Enhanced frequency of immunoregulatory invariant natural killer T cells in the airways of children with asthma J Allergy Clin Immunol 117 2006 217 218 (Pubitemid 43017166)
24. A Hamzaoui, S Cheik Rouhou, H Grairi, H Abid, J Ammar, H Chelbi et al. NKT cells in the induced sputum of severe asthmatics Mediators Inflamm 2006 2006 71214
25. P Vijayanand, G Seumois, C Pickard, RM Powell, G Angco, D Sammut et al. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease N Engl J Med 356 2007 1410 1422 (Pubitemid 46556326)
26. K Mutalithas, J Croudace, C Guillen, S Siddiqui, D Thickett, A Wardlaw et al. Bronchoalveolar lavage invariant natural killer T cells are not increased in asthma J Allergy Clin Immunol 119 2007 1274 1276 (Pubitemid 46654191)
27. P Matangkasombut, M Pichavant, T Yasumi, C Hendricks, PB Savage, RH Dekruyff et al. Direct activation of natural killer T cells induces airway hyperreactivity in nonhuman primates J Allergy Clin Immunol 121 2008 1287 1289
28. Yl Koh, JU Shim Association between sputum natural killer T cells and eosinophilic airway inflammation in human asthma Int Arch Allergy Immunol 153 2010 239 248
29. E Tupin, Y Kinjo, M Kronenberg The unique role of natural killer T cells in the response to microorganisms Nat Rev Microbiol 5 2007 405 417 (Pubitemid 46780078)
30. C Iwamura, T Nakayama Role of NKT cells in allergic asthma Curr Opin Immunol 22 2010 807 813
31. DT Umetsu, RH Dekruyff Natural killer T cells are important in the pathogenesis of asthma: the many pathways to asthma J Allergy Clin Immunol 125 2010 975 979
32. NA Molfino, PK Jeffery Chronic obstructive pulmonary disease: histopathology, inflammation and potential therapies Pulm Pharmacol Ther 20 2007 462 472 (Pubitemid 47077641)
33. S Joyce, L Van Kaer Lung NKT cell commotion takes your breath away Nat Med 14 2008 609 610 (Pubitemid 351809565)
34. EY Kim, JT Battaile, AC Patel, Y You, E Agapov, MH Grayson et al. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease Nat Med 14 2008 633 640 (Pubitemid 351809546)
35. RA Urbanowicz, JR Lamb, I Todd, JM Corne, LC Fairclough Altered effector function of peripheral cytotoxic cells in COPD Respir Res 10 2009 53
36. RA Urbanowicz, JR Lamb, I Todd, JM Corne, LC Fairclough Enhanced effector function of cytotoxic cells in the induced sputum of COPD patients Respir Res 11 2010 76
37. S Kobayashi, Y Kaneko, K Seino, Y Yamada, S Motohashi, J Koike et al. Impaired IFN-gamma production of Valpha24 NKT cells in non-remitting sarcoidosis Int Immunol 16 2004 215 222 (Pubitemid 38195651)
38. LP Ho, BC Urban, DR Thickett, RJ Davies, AJ McMichael Deficiency of a subset of T-cells with immunoregulatory properties in sarcoidosis Lancet 365 2005 1062 1072 (Pubitemid 40386784)
39. J Grunewald, A Eklund Role of CD4+ T cells in sarcoidosis Proc Am Thorac Soc 15 2007 461 464
40. P Korosec, M Rijavec, M Silar, I Kern, M Kosnik, K Osolnik Deficiency of pulmonary Valpha24 Vbeta11 natural killer T cells in corticosteroid-naive sarcoidosis patients Respir Med 104 2010 571 577
41. M Mempel, B Flageul, F Suarez, C Ronet, L Dubertret, P Kourilsky et al. Comparison of the T cell patterns in leprous and cutaneous sarcoid granulomas. Presence of Valpha24-invariant natural killer T cells in T-cell-reactive leprosy together with a highly biased T cell receptor Valpha repertoire Am J Pathol 157 2000 509 523 (Pubitemid 30627561)
42. P Korosec, K Osolnik, I Kern, M Silar, K Mohorcic, M Kosnik Expansion of pulmonary CD8+CD56+ natural killer T-cells in hypersensitivity pneumonitis Chest 132 2007 1291 1297 (Pubitemid 47621006)
43. MJ Pittet, DE Speiser, D Valmori, JC Cerottini, P Romero Cutting edge: cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression J Immunol 164 2000 1148 1152 (Pubitemid 30067223)
44. M Schuyler, K Gott, A Cherne, B Edwards Th1 CD4+ cells adoptively transfer experimental hypersensitivity pneumonitis Cell Immunol 177 1997 169 175 (Pubitemid 27244271)
45. G Gudmundsson, GW Hunninghake Interferon-gamma is necessary for the expression of hypersensitivity pneumonitis J Clin Invest 99 1997 2386 2390 (Pubitemid 27227715)
46. G Gudmundsson, MM Monick, GW Hunninghake IL-12 modulates expression of hypersensitivity pneumonitis J Immunol 161 1998 991 999 (Pubitemid 28323567)
47. H Yamasaki, M Ando, W Brazer, DM Center, WW Cruikshank Polarized type 1 cytokine profile in bronchoalveolar lavage T cells of patients with hypersensitivity pneumonitis J Immunol 163 1999 3516 3523 (Pubitemid 29431858)
48. T Ohkawa, S Seki, H Dobashi, Y Koike, Y Habu, K Ami et al. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells Immunology 103 2001 281 290 (Pubitemid 32626177)
49. JJ Campbell, S Qin, D Unutmaz, D Soler, KE Murphy, MR Hodge et al. Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire J Immunol 166 2001 6477 6482 (Pubitemid 32467184)
50. M Oshima, A Maeda, S Ishioka, K Hiyama, M Yamakido Expression of C-C chemokines in bronchoalveolar lavage cells from patients with granulomatous lung diseases Lung 177 1999 229 240 (Pubitemid 29328199)
51. J Konishi, K Yamazaki, H Yokouchi, N Shinagawa, K Iwabuchi, M Nishimura The characteristics of human NKT cells in lung cancer-CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients Hum Immunol 65 2004 1377 1388 (Pubitemid 39539204)
52. M Terabe, JA Berzofsky The role of NKT cells in tumor immunity Adv Cancer Res 101 2008 277 348
53. K Seino, S Motohashi, T Fujisawa, T Nakayama, M Taniguchi Natural killer T cell-mediated antitumor immune responses and their clinical applications Cancer Sci 97 2006 807 812 (Pubitemid 44151258)
54. JW Moiling, W Kolgen, HJ van der Vliet, MF Boomsma, H Kruizenga, CH Smorenburg et al. Peripheral blood IFN-y-secretingVa24+V|311+ NKT cell numbers are decreased in cancer patients independent of tumor type of tumor load Int J Cancer 116 2005 87 93 (Pubitemid 40827759)
55. SM Tahir, O Cheng, A Shaulov, Y Koezuka, GJ Bubley, SB Wilson et al. Loss of IFN-y production by invariant NKT cells in advanced cancer J Immunol 167 2001 4046 4050 (Pubitemid 32910851)
56. S Motohashi, Y Okamoto, I Yoshino, T Nakayama Anti-tumor immune responses induced by iNKT cell-based immunotherapy for lung cancer and head and neck cancer Clinical Immunology 2009 10.1016/j.dim.2011.01.009
57. M Taniguchi, T Tashiro, N Dashtsoodol, N Hongo, H Watarai The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy Int Immunol 22 2010 1 6
58. S Motohashi, K Nagato, N Kunii, H Yamamoto, K Yamasaki, K Okita et al. A phase l-ll study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer J Immunol 182 2009 2492 2501
59. Dl Godfrey, M Kronenberg Going both ways: immune regulation via CD1 d-dependent NKT cells J Clin Invest 114 2004 1379 1388 (Pubitemid 40385565)
60. JS Sutherland, DJ Jeffries, S Donkor, B Walther, PC Hill, IM Adetifa et al. High granulocyte/lymphocyte ratio and paucity of NKT cells defines TB disease in a TB-endemic setting Tuberculosis 89 2009 398 404
61. CJ Montoya, JC Catano, Z Ramirez, MT Rugeles, SB Wilson, AL Landay Invariant NKT cells from HIV-1 of Mycobacterium tuberculosis-infected patients express an activated phenotype Clin Immunol 127 2008 1 6
62. JS Im, TJ Kang, SB Lee, CH Kim, SH Lee, MM Venkataswamy et al. Alteration of the relative levels of iNKT cell subsets is associated with chronic mycobacterial infections Clin Immunol 127 2008 214 224 (Pubitemid 351474599)
63. V Lombardi, P Stock, AK Singh, J Kerzerho, W Yang, BA Sullivan et al. A CD1 d-dependent antagonist inhibits the activation of invariant NKT cells and prevents development of allergen-induced airway hyperreactivity J Immunol 184 2010 2107 2115